Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project

I. M. Graham, L. E. Daly, H. M. Refsum, K. Robinson, L. E. Brattstrom, P. M. Ueland, R. J. Palma-Reis, G. H. Boers, R. G. Sheahan, B. Israelsson, C. S. Uiterwaal, R. Meleady, D. McMaster, P. Verhoef, J. Witteman, P. Rubba, H. Bellet, J. C. Wautrecht, H. W. de Valk, A. C. Sales Luis, F. M. Parrot-Rouland, K. S. Tan, I. Higgins, D. Garcon, G. Andria and al. et
Department of Cardiology, Adelaide Hospital, Trinity College, Dublin, Ireland.

CONTEXT: Elevated plasma homocysteine is a known risk factor for atherosclerotic vascular disease, but the strength of the relationship and the interaction of plasma homocysteine with other risk factors are unclear. OBJECTIVE: To establish the magnitude of the vascular disease risk associated with an increased plasma homocysteine level and to examine interaction effects between elevated plasma homocysteine level and conventional risk factors. DESIGN: Case-control study. SETTING: Nineteen centers in 9 European countries. PATIENTS: A total of 750 cases of atherosclerotic vascular disease (cardiac, cerebral, and peripheral) and 800 controls of both sexes younger than 60 years. MEASUREMENTS: Plasma total homocysteine was measured while subjects were fasting and after a standardized methionine-loading test, which involves the administration of 100 mg of methionine per kilogram and stresses the metabolic pathway responsible for the irreversible degradation of homocysteine. Plasma cobalamin, pyridoxal 5'-phosphate, red blood cell folate, serum cholesterol, smoking, and blood pressure were also measured. RESULTS: The relative risk for vascular disease in the top fifth compared with the bottom four fifths of the control fasting total homocysteine distribution was 2.2 (95% confidence interval, 1.6-2.9). Methionine loading identified an additional 27% of at-risk cases. A dose-response effect was noted between total homocysteine level and risk. The risk was similar to and independent of that of other risk factors, but interaction effects were noted between homocysteine and these risk factors; for both sexes combined, an increased fasting homocysteine level showed a more than multiplicative effect on risk in smokers and in hypertensive subjects. Red blood cell folate, cobalamin, and pyridoxal phosphate, all of which modulate homocysteine metabolism, were inversely related to total homocysteine levels. Compared with nonusers of vitamin supplements, the small number of subjects taking such vitamins appeared to have a substantially lower risk of vascular disease, a proportion of which was attributable to lower plasma homocysteine levels. CONCLUSIONS: An increased plasma total homocysteine level confers an independent risk of vascular disease similar to that of smoking or hyperlipidemia. It powerfully increases the risk associated with smoking and hypertension. It is time to undertake randomized controlled trials of the effect of vitamins that reduce plasma homocysteine levels on vascular disease risk.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes
Wen et al.
CMAJ 2008;179:1263-1268.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia and Lower Extremity Wounds
Schwartzfarb and Romanelli
INT J LOW EXTREM WOUNDS 2008;7:126-136.
ABSTRACT  

Anesthetic Management of a Parturient with Hyperhomocysteinemia
Luzardo et al.
Anesth. Analg. 2008;106:1833-1836.
ABSTRACT | FULL TEXT  

Effect of Continuous Positive Airway Pressure Treatment on Serum Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome
Steiropoulos et al.
Chest 2007;132:843-851.
ABSTRACT | FULL TEXT  

Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis
Urquhart et al.
J Clin Pharmacol 2007;47:991-997.
ABSTRACT | FULL TEXT  

Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity
Ryan et al.
Thorax 2007;62:509-514.
ABSTRACT | FULL TEXT  

Protective Effect of Hydrogen Sulfide on Balloon Injury-Induced Neointima Hyperplasia in Rat Carotid Arteries
Meng et al.
Am. J. Pathol. 2007;170:1406-1414.
ABSTRACT | FULL TEXT  

Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects
Vanuzzo et al.
Eur Heart J 2007;28:484-491.
ABSTRACT | FULL TEXT  

Psoriasis and Risk of Myocardial Infarction
Malerba et al.
JAMA 2007;297:361-362.
FULL TEXT  

Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women
Ho et al.
Hum Reprod 2006;21:2715-2720.
ABSTRACT | FULL TEXT  

Letter by Powers et al Regarding Article, "Riboflavin Lowers Homocysteine in Individuals Homozygous for the MTHFR 677C->T Polymorphism"
Powers et al.
Circulation 2006;114:e65-e65.
FULL TEXT  

Human methionine synthase reductase is a molecular chaperone for human methionine synthase
Yamada et al.
Proc. Natl. Acad. Sci. USA 2006;103:9476-9481.
ABSTRACT | FULL TEXT  

Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
Aboyans et al.
Circulation 2006;113:2623-2629.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia Associated With Decreased Renal Transsulfuration Activity in Dahl S Rats
Li et al.
Hypertension 2006;47:1094-1100.
ABSTRACT | FULL TEXT  

Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease
Nylaende et al.
Vasc Med 2006;11:21-28.
ABSTRACT  

Serum cardiovascular risk factors in obstructive sleep apnea.
Can et al.
Chest 2006;129:233-237.
ABSTRACT | FULL TEXT  

Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses
Mtiraoui et al.
Reproduction 2006;131:395-401.
ABSTRACT | FULL TEXT  

Retinal Vein Occlusion, Homocysteine, and Methylene Tetrahydrofolate Reductase Genotype
McGimpsey et al.
IOVS 2005;46:4712-4716.
ABSTRACT | FULL TEXT  

5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement
Ozkul et al.
Br. J. Ophthalmol. 2005;89:1634-1637.
ABSTRACT | FULL TEXT  

Elevated Homocysteine as a Risk Factor for the Development of Diabetes in Women With a Previous History of Gestational Diabetes Mellitus: A 4-year prospective study
Cho et al.
Diabetes Care 2005;28:2750-2755.
ABSTRACT | FULL TEXT  

Total Plasma Homocysteine and Arteriosclerotic Outcomes in Type 2 Diabetes with Nephropathy
Friedman et al.
J. Am. Soc. Nephrol. 2005;16:3397-3402.
ABSTRACT | FULL TEXT  

Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
Spence et al.
Stroke 2005;36:2404-2409.
ABSTRACT | FULL TEXT  

A high-protein diet increases postprandial but not fasting plasma total homocysteine concentrations: a dietary controlled, crossover trial in healthy volunteers
Verhoef et al.
Am. J. Clin. Nutr. 2005;82:553-558.
ABSTRACT | FULL TEXT  

Spontaneous Isolated Posterior Communicating Artery Dissection in a Young Adult with Hyperhomocysteinemia
Duncan and Terblanche
Am. J. Neuroradiol. 2005;26:2030-2032.
ABSTRACT | FULL TEXT  

A Homocysteine Metabolism-Related Dietary Pattern and the Risk of Coronary Heart Disease in Two Independent German Study Populations
Weikert et al.
J. Nutr. 2005;135:1981-1988.
ABSTRACT | FULL TEXT  

Regulation of human methylenetetrahydrofolate reductase by phosphorylation
Yamada et al.
Proc. Natl. Acad. Sci. USA 2005;102:10454-10459.
ABSTRACT | FULL TEXT  

Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products
Robertson et al.
CMAJ 2005;172:1569-1573.
ABSTRACT | FULL TEXT  

Fractions of Total Plasma Homocysteine in Patients with Ischemic Stroke Before the Age of 55 Years
Sobol et al.
ANGIOLOGY 2005;56:201-209.
ABSTRACT  

Downstream effects on human low density lipoprotein of homocysteine exported from endothelial cells in an in vitro system
Nakano et al.
J. Lipid Res. 2005;46:484-493.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemic Diabetic Cardiomyopathy: Oxidative Stress, Remodeling, and Endothelial-Myocyte Uncoupling
Tyagi et al.
J CARDIOVASC PHARMACOL THER 2005;10:1-10.
ABSTRACT  

Homocysteine and cognitive function in elderly people
Garcia and Zanibbi
CMAJ 2004;171:897-904.
ABSTRACT | FULL TEXT  

Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C->T mutation on homocysteine concentrations in healthy adults: the ATTICA Study
Dedoussis et al.
Am. J. Clin. Nutr. 2004;80:849-854.
ABSTRACT | FULL TEXT  

Homocysteine and the Risk of Ischemic Stroke in a Triethnic Cohort: The Northern Manhattan Study
Sacco et al.
Stroke 2004;35:2263-2269.
ABSTRACT | FULL TEXT  

Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans
Verhoef et al.
Am. J. Clin. Nutr. 2004;80:674-679.
ABSTRACT | FULL TEXT  

Association of Serum Total Homocysteine with the Extent of Ischemic Heart Disease in a Mediterranean Cohort
Vrentzos et al.
ANGIOLOGY 2004;55:517-524.
ABSTRACT  

The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the 'ATTICA' study
Chrysohoou et al.
Vasc Med 2004;9:117-123.
ABSTRACT  

Plasma Homocysteine Level and the Angiographic Extent of Coronary Artery Disease
Bozkurt et al.
ANGIOLOGY 2004;55:265-270.
ABSTRACT  

Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death: The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial
Toole et al.
JAMA 2004;291:565-575.
ABSTRACT | FULL TEXT  

Betaine as a Determinant of Postmethionine Load Total Plasma Homocysteine Before and After B-Vitamin Supplementation
Holm et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:301-307.
ABSTRACT | FULL TEXT  

Variation in plasma cystathionine and its relation to changes in plasma concentrations of homocysteine and methionine in healthy subjects during a 24-h observation period
Guttormsen et al.
Am. J. Clin. Nutr. 2004;79:76-79.
ABSTRACT | FULL TEXT  

Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Refsum et al.
Clin. Chem. 2004;50:3-32.
ABSTRACT | FULL TEXT  

Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment
Bagi et al.
Am. J. Physiol. Heart Circ. Physiol. 2003;285:H2277-H2283.
ABSTRACT | FULL TEXT  

Plasma Homocysteine, Hypertension Incidence, and Blood Pressure Tracking: The Framingham Heart Study
Sundstrom et al.
Hypertension 2003;42:1100-1105.
ABSTRACT | FULL TEXT  

Review: Homocysteine, endothelial dysfunction and oxidative stress in type 1 diabetes mellitus
Wotherspoon et al.
British Journal of Diabetes & Vascular Disease 2003;3:334-340.
ABSTRACT  

Elevated Plasma Homocysteine Was Associated With Hemorrhagic and Ischemic Stroke, but Methylenetetrahydrofolate Reductase Gene C677T Polymorphism Was a Risk Factor for Thrombotic Stroke: A Multicenter Case-Control Study in China
Li et al.
Stroke 2003;34:2085-2090.
ABSTRACT | FULL TEXT  

Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine
Stuhlinger et al.
Circulation 2003;108:933-938.
ABSTRACT | FULL TEXT  

Comparative Effects of Atorvastatin, Simvastatin, and Fenofibrate on Serum Homocysteine Levels in Patients with Primary Hyperlipidemia
Milionis et al.
J Clin Pharmacol 2003;43:825-830.
ABSTRACT | FULL TEXT  

Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians
Herrmann et al.
Am. J. Clin. Nutr. 2003;78:131-136.
ABSTRACT | FULL TEXT  

New Markers for Cardiovascular Disease Risk in Women: Impact of Endogenous Estrogen Status and Exogenous Postmenopausal Hormone Therapy
Davison and Davis
J. Clin. Endocrinol. Metab. 2003;88:2470-2478.
ABSTRACT | FULL TEXT  

Homocysteine and Cerebral Infarction in Finnish Male Smokers
Fallon et al.
Stroke 2003;34:1359-1363.
ABSTRACT | FULL TEXT  

Betaine Supplementation Lowers Plasma Homocysteine in Healthy Men and Women
Steenge et al.
J. Nutr. 2003;133:1291-1295.
ABSTRACT | FULL TEXT  

Homocysteine and Risk of Recurrent Stroke
Boysen et al.
Stroke 2003;34:1258-1261.
ABSTRACT | FULL TEXT  

Care after Coronary-Artery Bypass Surgery
Charlson and Isom
NEJM 2003;348:1456-1463.
FULL TEXT  

Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994
Ganji and Kafai
Am. J. Clin. Nutr. 2003;77:826-833.
ABSTRACT | FULL TEXT  

Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults
Kluijtmans et al.
Blood 2003;101:2483-2488.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia Induces Renal Hemodynamic Dysfunction: Is Nitric Oxide Involved?
Fischer et al.
J. Am. Soc. Nephrol. 2003;14:653-660.
ABSTRACT | FULL TEXT  

New Insights into the tPA-Annexin A2 Interaction. IS ANNEXIN A2 CYS8 THE SOLE REQUIREMENT FOR THIS ASSOCIATION?
Roda et al.
J. Biol. Chem. 2003;278:5702-5709.
ABSTRACT | FULL TEXT  

Reducing Coronary Artery Disease by Decreasing Homocysteine Levels
Coffey et al.
Crit Care Nurse 2003;23:25-30.
FULL TEXT  

Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study
El-Khairy et al.
Am. J. Clin. Nutr. 2003;77:467-472.
ABSTRACT | FULL TEXT  

Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project
Meleady et al.
Am. J. Clin. Nutr. 2003;77:63-70.
ABSTRACT | FULL TEXT  

Update on Cobalamin, Folate, and Homocysteine
Carmel et al.
ASH Education Book 2003;2003:62-81.
ABSTRACT | FULL TEXT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects
De Bree et al.
Int J Epidemiol 2002;31:1268-1272.
FULL TEXT  

Cobalamin Status (Holo-Transcobalamin, Methylmalonic Acid) and Folate as Determinants of Homocysteine Concentration
Obeid et al.
Clin. Chem. 2002;48:2064-2065.
FULL TEXT  

Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration
JAMA 2002;288:2015-2022.
ABSTRACT | FULL TEXT  

MTHFR 677C->T Polymorphism and Risk of Coronary Heart Disease: A Meta-analysis
Klerk et al.
JAMA 2002;288:2023-2031.
ABSTRACT | FULL TEXT  

Smoking and plasma homocysteine
O'Callaghan et al.
Eur Heart J 2002;23:1580-1586.
ABSTRACT | FULL TEXT  

Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease
Eur Heart J 2002;23:1509-1515.
ABSTRACT | FULL TEXT  

Moderately Elevated Plasma Homocysteine, Methylenetetrahydrofolate Reductase Genotype, and Risk for Stroke, Vascular Dementia, and Alzheimer Disease in Northern Ireland
McIlroy et al.
Stroke 2002;33:2351-2356.
ABSTRACT | FULL TEXT  

Dyslipoproteinemia and Coronary Disease
Raos and Strujic
ANGIOLOGY 2002;53:557-562.
ABSTRACT  

Interlaboratory Variation of Plasma Total Homocysteine Measurements: Results of Three Successive Homocysteine Proficiency Testing Surveys
Hanson et al.
Clin. Chem. 2002;48:1539-1545.
ABSTRACT | FULL TEXT  

Folate Deficiency Alters Melatonin Secretion in Rats
Fournier et al.
J. Nutr. 2002;132:2781-2784.
ABSTRACT | FULL TEXT  

Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: Results of a meta-analysis
Kelly et al.
Neurology 2002;59:529-536.
ABSTRACT | FULL TEXT  

Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia
Weiss et al.
Vasc Med 2002;7:227-239.
ABSTRACT  

Homocysteine and "Buerger's disease"
Postgrad. Med. J. 2002;78:504-505.
FULL TEXT  

Association Between Homocysteinemia and Renal Function in Patients with Type 2 Diabetes Mellitus
Ozmen et al.
Annals of Clinical & Laboratory Science 2002;32:279-286.
ABSTRACT | FULL TEXT  

Plasma Total Homocysteine and Hospitalizations for Cardiovascular Disease: The Hordaland Homocysteine Study
Nurk et al.
Arch Intern Med 2002;162:1374-1381.
ABSTRACT | FULL TEXT  

Vitamins for Chronic Disease Prevention in Adults: Scientific Review
Fairfield and Fletcher
JAMA 2002;287:3116-3126.
ABSTRACT | FULL TEXT  

Protein-bound Homocystamide Measured in Human Plasma by HPLC
Uji et al.
Clin. Chem. 2002;48:941-944.
FULL TEXT  

Adverse Event Associated With Methionine Loading Test: A Case Report
Cottington et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1046-1050.
ABSTRACT | FULL TEXT  

Paradoxical overexpression and translocation of connexin43 in homocysteine-treated endothelial cells
Li et al.
Am. J. Physiol. Heart Circ. Physiol. 2002;282:H2124-H2133.
ABSTRACT | FULL TEXT  

Fortification of flour with folic acid
Reynolds and Sillender
BMJ 2002;324:918-918.
FULL TEXT  

Direct Assay for Cobalamin Bound to Transcobalamin (Holo-Transcobalamin) in Serum
Ulleland et al.
Clin. Chem. 2002;48:526-532.
ABSTRACT | FULL TEXT  

Plasma Homocysteine Concentration, C677T MTHFR Genotype, and 844ins68bp CBS Genotype in Young Adults With Spontaneous Cervical Artery Dissection and Atherothrombotic Stroke
Pezzini et al.
Stroke 2002;33:664-669.
ABSTRACT | FULL TEXT  

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT | FULL TEXT  

Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens
van der Griend et al.
Vasc Med 2002;7:29-33.
ABSTRACT  

5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women
Fohr et al.
Am. J. Clin. Nutr. 2002;75:275-282.
ABSTRACT | FULL TEXT  

Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
Ford et al.
Int J Epidemiol 2002;31:59-70.
ABSTRACT | FULL TEXT  

The MTHFR C677T, APOE, and PON55 Gene Polymorphisms Show Relevant Interactions with Cardiovascular Risk Factors
Murphy et al.
Clin. Chem. 2002;48:372-375.
FULL TEXT  

Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition
Wang et al.
Blood 2002;99:939-945.
ABSTRACT | FULL TEXT  

The effect of folic acid supplementation on plasma homocysteine in an elderly population
Rydlewicz et al.
QJM 2002;95:27-35.
ABSTRACT | FULL TEXT  

Cardiovascular disease risk factors and diet of Fulani pastoralists of northern Nigeria
Glew et al.
Am. J. Clin. Nutr. 2001;74:730-736.
ABSTRACT | FULL TEXT  

Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype
Pullin et al.
J Am Coll Cardiol 2001;38:1799-1805.
ABSTRACT | FULL TEXT  

Long-Term Homocysteine-Lowering Treatment With Folic Acid Plus Pyridoxine Is Associated With Decreased Blood Pressure but Not With Improved Brachial Artery Endothelium-Dependent Vasodilation or Carotid Artery Stiffness: A 2-Year, Randomized, Placebo-Controlled Trial
van Dijk et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:2072-2079.
ABSTRACT | FULL TEXT  

Deficiencies of folate and vitamin B6 exert distinct effects on homocysteine, serine, and methionine kinetics
Cuskelly et al.
Am. J. Physiol. Endocrinol. Metab. 2001;281:E1182-E1190.
ABSTRACT | FULL TEXT  

New Enzymatic Colorimetric Assay for Total Homocysteine
Matsuyama et al.
Clin. Chem. 2001;47:2155-2156.
FULL TEXT  

Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E
Bayes et al.
Nephrol Dial Transplant 2001;16:2172-2175.
ABSTRACT | FULL TEXT